| 发明名称 |
METHODS OF TREATING IMMUNE DISORDERS WITH SINGLE DOMAIN ANTIBODIES AGAINST TNF-ALPHA. |
| 摘要 |
<p>The invention relates to the TNFX binding molecule ozoralizumab (ATN-103), methods of using this molecule to treat immune disorders, including rheumatoid arthritis, and specific dosing regimens for the treatment of rheumatoid arthritis.</p> |
| 申请公布号 |
MX2013011216(A) |
申请公布日期 |
2013.10.17 |
| 申请号 |
MX20130011216 |
申请日期 |
2012.03.30 |
| 申请人 |
ABLYNX NV |
发明人 |
MARTIN HEGEN;GAIL COMER;AMARNATH SHARMA;KATHY SHIELDS |
| 分类号 |
C07K16/18;A61K39/395;A61P19/02;A61P37/06;C07K16/24;C07K16/46 |
主分类号 |
C07K16/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
